Evidence map›Paper›PMID 15923273›Full record

ArticleJournal of medical genetics2006

Skewed X chromosome inactivation and early-onset breast cancer.

J P Struewing, M A Pineda, M E Sherman, J Lissowska, L A Brinton, B Peplonska, A Bardin-Mikolajczak, M Garcia-Closas

Open access · greenAbstract read
In one paragraph

Article in Journal of medical genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Role ofInternational journal of clinical and experimental pathology · 2020
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

J P StruewingLaboratory of Population Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. js140a@nih.gov
M A Pineda
M E Sherman
J Lissowska
L A Brinton
B Peplonska
A Bardin-Mikolajczak
M Garcia-Closas
National Institutes of Health · USNational Cancer Institute · USThe Maria Sklodowska-Curie National Research Institute of Oncology · PLNofer Institute of Occupational Medicine · PL

Funding

HORMONE-RELATED CANCERSZ01CP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI BRINTON, LOUISE · 1996 to 2008
$11.2M
BREAST CANCER IN POLAND--STUDY TO ASSESS OCCUPA ANDN01CP091013 · CP · MARIE CURIE-SKLODOWSKA UNIVERSITY · PI ZATONSKI, WITOLD · 1999 to 2000
$495k
Genetic Epidemiology of BRCA12Z01CP010138 · NCI · CANCER EPIDEMIOLOGY AND GENETICS · PI STRUEWING, JEFFERY P · 1999 to 2007
$252k
Identification of Non-BRCA12 Susceptibility Genes in Special PopulationsZ01BC010559 · NCI · BASIC SCIENCES · PI STRUEWING, JEFFERY P · 2005 to 2007
$157k
Intramural NIH HHSNCI NIH HHS N01-CP-91013NCI NIH HHS Z01 CP010138-08
6 · The paper itself

Abstract

backgroundSkewed X chromosome inactivation may be more common in women with epithelial ovarian cancer and early-onset breast cancer. We tested this hypothesis in a group of 235 breast cancer patients and 253 controls (mean age 45.8 years) from a larger population based case control study.

methodsWe measured X chromosome inactivation with the AR gene assay in lymphocyte DNA digested with the methylation specific enzyme HpaII. We judged skewness using an adjusted measure (relative to the undigested sample) with a cut point of 75%, and an unadjusted measure where skewed was defined as > 90% of the signal from one allele in the HpaII digested sample.

resultsThere were no significant differences in any of the skewing measures between cases and controls. Using the adjusted skewing measure among pre-menopausal subjects under the age of 50, 14% of cases versus 11% of controls were skewed, OR = 1.2, 95% CI 0.6 to 2.3; using the unadjusted measure, OR = 0.9, 95% CI 0.4 to 2.0.

conclusionsWhile we cannot rule out a subtle difference of approximately twofold or less, we have failed to find a significant difference in the prevalence of skewed X chromosome inactivation in younger women with breast cancer compared to controls.

Indexed as

AdultAgedAge of OnsetBreast NeoplasmsCase-Control StudiesFemaleGenetic Predisposition to DiseaseHumansMiddle AgedX Chromosome Inactivation

Identifiers

PMID15923273
PMCPMC1876702
OpenAlexW2145190496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.